BioMed Research International

Research Article

EULAR Task Force Recommendations on Annual Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis: An Audit of the Success of Implementation in a Rheumatology Outpatient Clinic

Table 1

Cardiovascular risk factors recorded in patients attending a rheumatology outpatient clinic.
Risk factor recorded in the patient journal (%)ROC 
()		AC  
()		RegROC  
()		OR* 
(95% CI)		AC versus RegROC  
value*
Blood pressure576 
(50.4)		421 
(79.4)		155 
(25.3)		12.36 
(9.27, 16.48)		<0.001
Total cholesterol537 
(47.0)		354 
(66.8)		183 
(29.9)		5.02 
(3.89, 6.48)		<0.001
LDL-cholesterol503 
(44.1)		347 
(65.5)		156 
(25.5)		5.87 
(4.53, 7.62)		<0.001
HDL-cholesterol515 
(45.1)		350 
(66.0)		165 
(27.0)		5.59 
(4.31, 7.23)		<0.001
Triglycerides472 
(41.3)		333 
(62.8)		139 
(22.7)		6.02 
(4.63, 7.82)		<0.001
Fasting blood glucose351 
(30.7)		281 
(53.0)		70 
(11.4)		9.11 
(6.71, 12.35)		<0.001
HbA1c385 
(33.7)		284 
(53.6)		101 
(16.5)		6.10 
(4.62, 8.04)		<0.001
Smoking756 
(66.2)		378 
(69.3)		378 
(61.8)		1.44 
(1.12, 1.85)		0.05
Complete risk profile included in the SCORE algorithm307 
(26.9)		276 
(52.1)		31 
(5.1)		20.97 
(14.04, 31.33)		<0.001
Cardioprotective medication251 
(22.0)		198 
(37.4)		53 
(8.7)		6.31 
(4.52, 8.82)		<0.001
CVD comorbidities231 
(20.2)		184 
(34.7)		47 
(7.7)		6.43 
(4.53, 9.14)		<0.001
Adjusted for age and gender.
ROC: rheumatology outpatient clinic of the Hospital of Southern Norway, RegROC: regular rheumatology outpatient clinic, AC: arthritis clinic, OR: odds ratio, CI: confidence interval, CVD: Cardiovascular disease, LDL: low-density lipoprotein, HDL: high-density lipoprotein, HbA1c: glycated haemoglobin, complete risk profile: complete lipid values (total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides), smoking, and blood pressure, SCORE: systematic coronary risk evaluation, cardioprotective medication: antihypertensives and statins, and CVD comorbidities: hypertension, angina pectoris, acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft surgery, cerebrovascular accident, and premature familiar cardiovascular disease.